Differentiating Carotid Free-Floating Thrombus From Atheromatous Plaque Using Intraluminal Filling Defect Length on CTA: A Validation Study
| Autor: | Dylan Blacquiere, Franco Momoli, Cheemun Lum, Paulo Puac-Polanco, Aditya Bharatha, Bijoy K Menon, Ronda Lun, Carlos Torres, Dar Dowlatshahi, Michel Shamy, Rebecca E. Thornhill, Prasham Dave, Grant Stotts |
|---|---|
| Rok vydání: | 2020 |
| Předmět: |
Carotid Artery Diseases
Male Validation study Computed Tomography Angiography Sensitivity and Specificity Free floating thrombus Filling defect medicine Humans Prospective Studies Thrombus Stroke Aged Ischemic Stroke Aged 80 and over business.industry Area under the curve Thrombosis Middle Aged medicine.disease Confidence interval Plaque Atherosclerotic Atheroma Ischemic Attack Transient Female Neurology (clinical) Nuclear medicine business |
| Zdroj: | Neurology. 97(8) |
| ISSN: | 1526-632X |
| Popis: | ObjectiveTo validate a previously proposed filling defect length threshold of >3.8 mm on CT angiography (CTA) to discriminate between free-floating thrombus (FFT) and plaque of atheroma.MethodsThis was a prospective multicenter observational study of 100 participants presenting with TIA/stroke symptoms and a carotid intraluminal filling defect on initial CTA. Follow-up CTA was obtained within 1 week and at weeks 2 and 4 if the intraluminal filling defect was unchanged in length. Resolution or decreased length was diagnostic of FFT, whereas its static appearance after 4 weeks was indicative of plaque. Diagnostic accuracy of FFT length was assessed by receiver operating characteristic analysis.ResultsNinety-five participants (mean [SD] age 68 [13] years, 61 men, 83 participants with FFT, 12 participants with a plaque) were evaluated. The >3.8-mm threshold had a sensitivity of 88% (73 of 83) (95% confidence interval [CI] 78%–94%) and specificity of 83% (10 of 12) (95% CI 51%–97%) (area under the curve 0.91,p< 0.001) for the diagnosis of FFT. The optimal length threshold was >3.64 mm with a sensitivity of 89% (74 of 83) (95% CI 80%–95%) and specificity of 83% (10 of 12) (95% CI 51%–97%). Adjusted logistic regression showed that every 1-mm increase in intraluminal filling defect length is associated with an increase in odds of FFT of 4.6 (95% CI 1.9–11.1,p= 0.01).ConclusionCTA enables accurate differentiation of FFT vs plaque using craniocaudal length thresholds.Trial Registration InformationClinicalTrials.gov Identifier:NCT02405845.Classification of EvidenceThis study provides Class I evidence that in patients with TIA/stroke symptoms, the presence of CTA-identified filling defects of lengths >3.8 mm accurately discriminates FFT from atheromatous plaque. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|